Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the University Acquisition Oversight topic
No spam. Unsubscribe anytime.
Senator seeks legislative review of University of Nebraska deals worth more than $100 million
Summary
Sen. Tony Sorrentino’s LB1125 would require legislative approval before the University of Nebraska could acquire a controlling interest in a hospital or health facility valued over $100,000,000. Sponsors raised concerns about an $800 million proposed transaction involving Nebraska Medicine; the University urged the committee not to advance the bill, and Clarkson College testified neutrally about institutional risks to the college.
Senator Tony Sorrentino opened the Executive Board hearing on LB1125 by saying the bill would require legislative approval for any University of Nebraska contract that acquires a controlling interest in a hospital or health care facility valued at more than $100,000,000. He framed the measure as a transparency and oversight response to a proposed University transaction involving Nebraska Medicine that he described as a roughly $800,000,000 undertaking.
Sorrentino described elements of the transaction as including a $500,000,000 buyout of Clarkson’s 50% share of Nebraska Medicine, $300,000,000 for land and buildings associated with the hospital and clinics, and a $200,000,000 pledged donation from Clarkson toward a university initiative. He said the bill is intended as a limited review mechanism—not a complete restructuring of university authority—but argued the Legislature has a vested interest because of the university’s reliance on state appropriations and the potential fiscal implications for taxpayers.
Matt Blomstedt testified on behalf of the University of Nebraska in opposition. Blomstedt argued the university’s constitutional governance—an elected Board of Regents—provides public accountability and that moving decision‑making toward the Legislature could undermine the board’s authority and predictable long‑term planning. He listed recent major university projects overseen by the regents and said those projects involved appropriate oversight when state funding was requested.
Andrea Nebelks, president and CEO of Clarkson College, testified in a neutral capacity. Nebelks said the college is institutionally connected to Nebraska Medicine (employees, benefits and leases run through the hospital), that public confusion about the transaction had generated concern among students and alumni, and that public materials did not clearly state what would happen to land, buildings or advancement assets tied to Clarkson College.
Committee members asked whether a final purchase agreement exists, how confidentiality agreements during negotiation constrain oversight, and whether the $100 million threshold is appropriate. Blomstedt said he could not confirm the contract status in the hearing and emphasized the need for continued dialogue. Sorrentino asked the committee to advance LB1125 to general file for further debate, but the transcript records no committee vote or other formal action during the hearing.
The Executive Board recorded 37 written letters in support, five in opposition and one neutral for LB1125; the hearing closed with no recorded committee vote.
